Tag Archives: MED

Top 10 Value Stocks To Buy For 2019

The big day is rapidly approaching. In just over a month, on Oct. 17, recreational marijuana will go on sale in licensed dispensaries throughout Canada. When fully legal, the sale of adult-use weed is expected to usher in high demand and big dollar figures for the industry.

In anticipation of this legalization — and the big profits that are projected to follow — marijuana stock investors and Wall Street have pushed the valuations of many pot stocks into nosebleed territory. Some of these marijuana stocks are still valued modestly below Wall Street’s consensus price target per share. Conversely, there are a handful of top marijuana stocks whose price targets are well below their current share price. Keeping in mind that Wall Street price targets are nothing more than dart throws by analysts, here are three top marijuana stocks that are expected to lose at least a quarter of their value.

Image source: Getty Images.

Top 10 Value Stocks To Buy For 2019: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Logan Wallace]

    State Board of Administration of Florida Retirement System raised its stake in Medifast Inc (NYSE:MED) by 12.4% during the second quarter, HoldingsChannel reports. The institutional investor owned 5,781 shares of the specialty retailer’s stock after buying an additional 640 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Medifast were worth $926,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. The official website for MediBloc [QRC20] is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here. MediBloc [QRC20]’s official message board is medium.com/@MediBloc.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 20 percent to $119 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Ethan Ryder]

    MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 22 percent to $121.06 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Sean Williams]

    Meanwhile, Medifast’s (NYSE:MED) share price has tripled since the beginning of March. Medifast’s second-quarter operating results showcased a 55% increase in sales and an 84% improvement in year-over-year adjusted earnings per share. A substantial increase in Optavia-branded products sold, along with a big jump in active earning coaches, drove results. The company also substantially lifted its full-year sales and profit guidance (close to 20% at the midpoint for both measures). 

Top 10 Value Stocks To Buy For 2019: Hingham Institution for Savings(HIFS)

Advisors’ Opinion:

  • [By Max Byerly]

    Port Capital LLC lifted its stake in Hingham Institution for Savings (NASDAQ:HIFS) by 14.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,159 shares of the savings and loans company’s stock after purchasing an additional 5,943 shares during the quarter. Hingham Institution for Savings accounts for approximately 1.4% of Port Capital LLC’s holdings, making the stock its 25th biggest position. Port Capital LLC owned approximately 2.28% of Hingham Institution for Savings worth $9,921,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Hingham Institution for Savings (NASDAQ:HIFS) and SVB Financial Group (NASDAQ:SIVB) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, earnings, analyst recommendations and dividends.

  • [By Joseph Griffin]

    Epoch Investment Partners Inc. grew its stake in Hingham Institution for Savings (NASDAQ:HIFS) by 71.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 92,261 shares of the savings and loans company’s stock after purchasing an additional 38,440 shares during the quarter. Epoch Investment Partners Inc. owned approximately 4.37% of Hingham Institution for Savings worth $19,006,000 as of its most recent SEC filing.

Top 10 Value Stocks To Buy For 2019: lululemon athletica inc.(LULU)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos, Jeremy Bowman, and Steve Symington]

    With that in mind, Motley Fool investors scoured the industry for examples of retailers that boast attractive long-run growth opportunities. Read on to find out why Five Below (NASDAQ:FIVE), lululemon (NASDAQ:LULU), and Boot Barn (NYSE:BOOT) topped that list. 

  • [By Jeremy Bowman]

    Meanwhile, Under Armour’s rivals like Nike (NYSE:NKE), Adidas (NasdaqOTC: ADDYY), and lululemon athletica (NASDAQ:LULU) all performed well in the survey. Piper Jaffray found that Adidas was the fastest-growing brand in the survey, which follows Adidas’s recent stock surge and sales and profit growth. Its Originals, or classic sneakers, like the Stan Smith and the Superstar were especially popular last year. The Superstar, in fact, was the No. 1-selling sneaker last year, according to NPD Group, dethroning Nike for the first time in more than a decade.  

  • [By John Ballard]

    However, Nike’s core business is still selling sneakers. That’s not going to change, and that’s also why lululemon athletica (NASDAQ:LULU) should continue to do fine. Just as Nike has been successful turning a basketball shoe into a fashion statement, Lululemon has accomplished the same in athletic apparel. Both companies are really good at what they do best, and that will protect Lululemon’s competitive position from larger rivals.

Top 10 Value Stocks To Buy For 2019: ATA Inc.(ATAI)

Advisors’ Opinion:

  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Top 10 Value Stocks To Buy For 2019: Amtech Systems Inc.(ASYS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ValuEngine cut shares of Amtech Systems (NASDAQ:ASYS) from a hold rating to a sell rating in a research note published on Wednesday morning.

    Separately, Zacks Investment Research raised Amtech Systems from a sell rating to a hold rating in a research report on Monday, April 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of $14.88.

  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Stephan Byrd]

    Brooks Automation (NASDAQ: BRKS) and Amtech Systems (NASDAQ:ASYS) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

  • [By Stephan Byrd]

    SUMITOMO HEAVY/ADR (NASDAQ: ASYS) and Amtech Systems (NASDAQ:ASYS) are both industrial products companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Top 10 Value Stocks To Buy For 2019: Imprimis Pharmaceuticals, Inc.(IMMY)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Stephan Byrd]

    Headlines about Imprimis Pharmaceuticals (NASDAQ:IMMY) have been trending positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imprimis Pharmaceuticals earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave media headlines about the specialty pharmaceutical company an impact score of 47.393314841388 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t

Top 10 Value Stocks To Buy For 2019: Newmont Mining Corporation(NEM)

Advisors’ Opinion:

  • [By Scott Levine]

    In one of the gold industry’s most notable news stories last month, Goldcorp announced that it had entered into a definitive agreement with Newmont Mining (NYSE:NEM) in which Newmont will acquire all outstanding shares of Goldcorp’s common stock in a deal valued at $10 billion. Newmont will acquire each Goldcorp share for 0.3280 of a Newmont share, representing a 17% premium based on the companies’ 20-day volume weighted average share prices. The transaction is expected to close in the second quarter of 2019 and has already been approved by both companies’ boards of directors.

  • [By Trey Thoelcke]

    Newmont Mining Corp. (NYSE: NEM) is scheduled to report its fourth-quarter results before Thursday’s open. The consensus estimates call for EPS of $0.25 and $1.88 billion in revenue. Shares closed at $33.24 on Friday. The consensus price target is $40.00, and the 52-week trading range is $29.06 to $41.98.

  • [By Paul Ausick]

    Just a week ago today, Barrick Gold Corp. (NYSE: GOLD) announced an unsolicited offer to acquire rival miner Newmont Mining Corp. (NYSE: NEM) for $18 billion. The all-stock offer was rejected Monday morning by Newmont’s board of directors in a decision that was entirely predictable. Less predictable, perhaps, was Newmont’s counteroffer of a joint venture between the two firms’ Nevada operations.

  • [By Joseph Griffin]

    Boston Partners boosted its holdings in shares of Newmont Mining Co. (NYSE:NEM) by 4.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,976 shares of the basic materials company’s stock after buying an additional 2,033 shares during the quarter. Boston Partners’ holdings in Newmont Mining were worth $1,992,000 at the end of the most recent quarter.

Top 10 Value Stocks To Buy For 2019: Clearside BioMedical, Inc. (CLSD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Clearside Biomedical, Inc. (NASDAQ: CLSD) was down, falling around 26 percent to $10.775. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.

  • [By Chris Lange]

    Clearside Biomedical Inc. (NASDAQ: CLSD) shares dropped early on Thursday after the company released data from its midstage clinical trial for diabetic macular edema (DME). Specifically, this data came from the Phase 2 clinical trial (TYBEE) evaluating suprachoroidal CLS-TA used with intravitreally administered Eylea (aflibercept).

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares fell 17.8 percent to $11.95 in pre-market trading. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    CRISPR Therapeutics AG (NASDAQ: CRSP) fell 15.8 percent to $62.00 in pre-market trading after the company disclosed that the FDA has placed a clinical hold on IND for CTX001 sickle cell disease treatment.
    Sears Holdings Corporation (NASDAQ: SHLD) fell 10 percent to $2.89 in pre-market trading after the company posted a loss for the first quarter and announced plans to close 72 non-profitable stores.
    Urban One, Inc. (NASDAQ: UONE) fell 9 percent to $3.01 in pre-market trading after rising 78.38 percent on Wednesday.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares fell 8.6 percent to $88.05 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Ciena Corporation (NYSE: CIEN) fell 8.5 percent to $22.02 in the pre-market trading session after the company posted downbeat Q1 earnings and announced plans to buy Packet Design.
    Dollar General Corporation (NYSE: DG) shares fell 6.6 percent to $90.11 in pre-market trading after reporting weaker-than-expected results for its first quarter.
    Vericel Corp (NASDAQ: VCEL) shares fell 6.5 percent to $13.05 in pre-market trading following announcement of 3.75 million share common stock offering.
    Box, Inc. (NYSE: BOX) fell 5.7 percent to $26.19 in pre-market trading. Box reported upbeat results for its first quarter. The company forecast Q2 revenue of $146 million to $147 million.
    Co-Diagnostics, Inc. (NASDAQ: CODX) fell 5.7 percent to $3.15 in pre-market trading after declining 5.65 percent on Wednesday.
    Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) shares fell 5.2 percent to $18.21 in pre-market trading after reporting a 2

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (NASDAQ: CLSD) and Bluebird Bio (NASDAQ … (analystratings.com) Catabasis launches public equity offering (seekingalpha.com) Friedreich Ataxia Market Pipeline Therapeutics 2018 Top Key Players, Drug Profile and Product Description (thecleantechnology.com) Cellectis SA Receives a Buy from Oppenheimer (analystratings.com) Global Type I Hyperlipoproteinemia Drug Market 2018- Catabasis Pharmaceuticals, Inc., uniQure NV , Isis … (afinancialanalysis.com)

    Shares of Catabasis Pharmaceuticals traded down $0.28, reaching $1.06, on Monday, Marketbeat reports. The company’s stock had a trading volume of 2,344,684 shares, compared to its average volume of 645,019. The firm has a market cap of $38.91 million, a price-to-earnings ratio of -0.84 and a beta of 0.74. Catabasis Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $3.78.

  • [By Ethan Ryder]

    Shares of Clearside Biomedical Inc (NASDAQ:CLSD) have earned a consensus recommendation of “Buy” from the ten brokerages that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $22.40.

Top 10 Value Stocks To Buy For 2019: Bassett Furniture Industries Incorporated(BSET)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about Bassett Furniture Industries (NASDAQ:BSET) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Bassett Furniture Industries earned a news impact score of 0.08 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.0883846805754 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Value Stocks To Buy For 2019: Eaton Vance Short Diversified Income Fund(EVG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    EATON VANCE SHO/COM (NYSE:EVG) declared a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Investors of record on Friday, September 21st will be paid a dividend of 0.065 per share on Friday, September 28th. This represents a $0.78 dividend on an annualized basis and a yield of 6.06%. The ex-dividend date is Thursday, September 20th.

Hot Clean Energy Stocks To Invest In Right Now

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-951753282&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/951753282/960×0.jpg?fit=scale&q; data-height=&q;639&q; data-width=&q;960&q;&g; A worker installs solar panels atop a house in the Netherlands. (Photo by Yuriko Nakao/Getty Images)

&l;p class=&q;tweet_line&q;&g;More than half a million jobs around the world were created in the renewable energy sector in 2017 , bringing the total number of people employed in the sector to more than 10 million for the first time.

Figures from the International Renewable Energy Agency (IRENA) show that more than 70% of clean energy jobs are in just six countries &a;ndash; China, Brazil, the US, India, Germany and Japan &a;ndash; suggesting the sector has significant scope to continue growing in years to come.

IRENA&a;rsquo;s fifth &l;em&g;Renewable Energy and Jobs &a;ndash; Annual Review&l;/em&g; showed that the sector employs 10.3 million workers, with 60% of jobs in Asia. &a;ldquo;Although growing numbers of countries are reaping the socio-economic benefits of renewables, the bulk of manufacturing takes place in relatively few countries and domestic markets vary enormously in size,&a;rdquo; IRENA said.

Hot Clean Energy Stocks To Invest In Right Now: Universal Stainless & Alloy Products, Inc.(USAP)

Advisors’ Opinion:

  • [By Max Byerly]

    Universal Stainless & Alloy Products (NASDAQ:USAP) and EVRAZ (OTCMKTS:EVRZF) are both basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, earnings, risk and institutional ownership.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Universal Stainless & Alloy Products (USAP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of Universal Stainless & Alloy Products, Inc. (NASDAQ:USAP) traded down 0% on Friday . The company traded as low as $24.22 and last traded at $24.53. 505,097 shares were traded during trading, an increase of 1,278% from the average session volume of 36,661 shares. The stock had previously closed at $24.53.

  • [By Ethan Ryder]

    Universal Stainless & Alloy Products (NASDAQ: USAP) and SUMITOMO Corp/S (OTCMKTS:SSUMY) are both basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Universal Stainless & Alloy Products (USAP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Clean Energy Stocks To Invest In Right Now: Marlin Business Services Corp.(MRLN)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Marlin Business Services Corp  (NASDAQ:MRLN)Q4 2018 Earnings Conference CallFeb. 01, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    First Bank (NASDAQ: FRBA) and Marlin Business Services (NASDAQ:MRLN) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

  • [By Max Byerly]

    Marlin Business Services (NASDAQ:MRLN) and MID-SOUTHERN Sv/SH (OTCMKTS:MSVB) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

  • [By Ethan Ryder]

    TIAA CREF Investment Management LLC reduced its position in Marlin Business Services Corp. (NASDAQ:MRLN) by 12.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,342 shares of the financial services provider’s stock after selling 2,468 shares during the quarter. TIAA CREF Investment Management LLC owned about 0.14% of Marlin Business Services worth $500,000 at the end of the most recent reporting period.

Hot Clean Energy Stocks To Invest In Right Now: Vicon Industries Inc.(VII)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Kopin alerts:

    Global Microdisplay Market Report 2018-2023 eMagin Corporation, Kopin Corporation, LG Display Co., Ltd., AU … (ittechnology24.com) Price Performance Review on Shares of Kopin Cp (KOPN): Move 3.12% (parkcitycaller.com) MAMA Cross Spotted in Kopin Cp (KOPN) Shares (fisherbusinessnews.com) Is Kopin Corporation (NasdaqGS:KOPN) Generating Enough Return on Equity? (derbynewsjournal.com) Hot Stocks- Vicon Industries, Inc. (NYSE:VII), Kopin Corporation (NASDAQ:KOPN), Mannatech, Incorporated (NASDAQ … (journalfinance.net)

    Shares of Kopin traded up $0.03, reaching $3.34, on Monday, Marketbeat Ratings reports. The stock had a trading volume of 101,064 shares, compared to its average volume of 263,988. Kopin has a fifty-two week low of $2.80 and a fifty-two week high of $4.60.

  • [By Shane Hupp]

    Vicon Industries, Inc. (NYSEAMERICAN:VII) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 249,394 shares, a decrease of 30.9% from the April 30th total of 361,136 shares. Based on an average daily volume of 173,799 shares, the days-to-cover ratio is currently 1.4 days. Approximately 3.0% of the shares of the company are sold short.

  • [By Stephan Byrd]

    Seven Generations Energy (TSE:VII) insider Glen Allen Nevokshonoff sold 31,319 shares of the business’s stock in a transaction on Thursday, May 10th. The stock was sold at an average price of C$16.15, for a total transaction of C$505,801.85.

Hot Clean Energy Stocks To Invest In Right Now: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Max Byerly]

    MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. The official website for MediBloc [QRC20] is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here. MediBloc [QRC20]’s official message board is medium.com/@MediBloc.

  • [By Logan Wallace]

    MediBloc [MED] (CURRENCY:MED) traded 11.7% lower against the U.S. dollar during the 1 day period ending at 20:00 PM ET on February 16th. MediBloc [MED] has a total market capitalization of $19.63 million and $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours. During the last seven days, MediBloc [MED] has traded down 27.6% against the U.S. dollar. One MediBloc [MED] token can currently be bought for $0.0066 or 0.00000100 BTC on major exchanges including Coinrail, Bibox and Gate.io.

  • [By Max Byerly]

    MediBloc (CURRENCY:MED) traded 0.2% lower against the U.S. dollar during the twenty-four hour period ending at 16:00 PM Eastern on June 7th. MediBloc has a total market cap of $37.92 million and $586,074.00 worth of MediBloc was traded on exchanges in the last 24 hours. Over the last week, MediBloc has traded down 36% against the U.S. dollar. One MediBloc token can now be purchased for $0.0128 or 0.00000166 BTC on major exchanges including Coinrail, Bibox and Gate.io.

  • [By Logan Wallace]

    State Board of Administration of Florida Retirement System raised its stake in Medifast Inc (NYSE:MED) by 12.4% during the second quarter, HoldingsChannel reports. The institutional investor owned 5,781 shares of the specialty retailer’s stock after buying an additional 640 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Medifast were worth $926,000 at the end of the most recent reporting period.

Hot Clean Energy Stocks To Invest In Right Now: Innoviva, Inc. (INVA)

Advisors’ Opinion:

  • [By Sean Williams]

    After running a screen for healthcare stocks with a PEG ratio below 1 (courtesy of Yahoo! Finance), the following 13 were all that remained:

    Innoviva (NASDAQ:INVA): 0.42 PEG ratio Celgene (NASDAQ:CELG): 0.54 Mallinckrodt (NYSE:MNK): 0.59 Exelixis (NASDAQ:EXEL): 0.60 Global Cord Blood Corp.: 0.72 AbbVie: 0.75 Vertex Pharmaceuticals: 0.80 DaVita: 0.80 Supernus Pharmaceuticals: 0.80 Mednax: 0.82 MiMedx Group: 0.88 CIGNA: 0.93 Medpace Holdings: 0.95

    Image source: Getty Images.

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we asked three Motley Fool investors to name one healthcare stock that’s tops on their list for the month of June. These three mid-cap stocks made the cut: royalty drug company Innoviva (NASDAQ:INVA), mental illness treatment center operator Acadia Healthcare (NASDAQ:ACHC), and health savings account provider HealthEquity (NASDAQ:HQY).

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Innoviva (INVA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Virginia Retirement Systems ET AL lifted its holdings in shares of Innoviva Inc (NASDAQ:INVA) by 67.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 145,100 shares of the biotechnology company’s stock after acquiring an additional 58,700 shares during the period. Virginia Retirement Systems ET AL’s holdings in Innoviva were worth $2,002,000 at the end of the most recent reporting period.

  • [By Sean Williams]

    Lastly, there’s Innoviva (NASDAQ:INVA), which isn’t a traditional drug stock, per se. Innoviva is a royalty company that’s currently reaping benefits from a group of long-lasting COPD and asthma medications that were developed in cooperation with GlaxoSmithKline (NYSE:GSK). You know these medicines today as Breo Ellipta and Anoro Ellipta, to name a few.

Hot Clean Energy Stocks To Invest In Right Now: Tower International, Inc.(TOWR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Tower International (TOWR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Here are some of the news articles that may have impacted Accern’s analysis:

    Get Tower International alerts:

    Bridging North America will build Gordie Howe International Bridge (windsorstar.com) Woods Bagot Unveils Design of Firm’s First Grade a Office Tower in Manila (dexigner.com) Gordie Howe International Bridge will be longest cable-stayed bridge in North America (clickondetroit.com) China Tower Is Said to Start Gauging Demand for Hong Kong IPO (bloomberg.com) Brokerages Expect Tower International Inc (TOWR) Will Announce Earnings of $1.08 Per Share (americanbankingnews.com)

    TOWR has been the topic of several recent analyst reports. Zacks Investment Research upgraded Tower International from a “hold” rating to a “buy” rating and set a $30.00 target price on the stock in a research report on Saturday, May 5th. ValuEngine downgraded Tower International from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, May 2nd. Finally, Roth Capital initiated coverage on Tower International in a research report on Thursday, May 24th. They set a “buy” rating and a $41.00 target price on the stock. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $35.50.

  • [By Ethan Ryder]

    Tower International (NYSE:TOWR) was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a report released on Wednesday.

Top 10 Growth Stocks To Buy Right Now

Good morning Americas, Here’s news from Bloomberg Economics to help get your week started:

President Donald Trump is headed for a showdown with America’s allies at a Group of Seven summit this week in Quebec, with the European Union and Canada threatening retaliatory measures unless he reverses course on new steel and aluminum levies.The meeting comes after G-7 finance ministers rebuked the U.S., and allies asking Trump to consider a change of heartMeanwhile, China says all deals are off if fresh tariffs are imposed and Singapore thinks both sides are raising global risksCommerce Secretary Wilbur Ross was in Beijing this weekend to push China on trade, while White House economic adviser Larry Kudlow says not to blame Trump Investors are worried that political upheaval in Italy will derail euro-area economic growthAt the same time, Greece is giving Europe another headache as talks on further debt relief are at a stalemate with two months to go before expiration of the euro area’s final crisis-era bailoutGermany’s economy may be booming, but we ask why women aren’t feeling the gains

Top 10 Growth Stocks To Buy Right Now: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media stories about Trueblue (NYSE:TBI) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.3296498009881 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Stephan Byrd]

    Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Trueblue (TBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Growth Stocks To Buy Right Now: Buffalo Wild Wings Inc.(BWLD)

Advisors’ Opinion:

  • [By Steve Symington]

    That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen’s clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby’s Restaurant Group:

Top 10 Growth Stocks To Buy Right Now: Intuitive Surgical Inc.(ISRG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    MSA Safety (NYSE: MSA) and Intuitive Surgical (NASDAQ:ISRG) are both industrial products companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability and institutional ownership.

  • [By Ethan Ryder]

    These are some of the news stories that may have effected Accern Sentiment Analysis’s scoring:

    Get Intuitive Surgical alerts:

    Global Commercial Robotics Market 2018 by Key Players – INTUITIVE SURGICAL INC , YASKAWA ELECTRIC … (themobileherald.com) Bullish or Bearish Territory: Intuitive Surgical, Inc. (ISRG) (nysestocks.review) Intuitive Surgical, Inc. (ISRG) -Price to Earnings Ratio Evaluation (P/E) (nasdaqfortune.com) Stock in Featured List: Intuitive Surgical, Inc. (ISRG) (stockquote.review) Intuitive Surgical (ISRG) Gains on Strength in Robotics (finance.yahoo.com)

    A number of brokerages have recently weighed in on ISRG. Cantor Fitzgerald reissued a “buy” rating and issued a $490.00 price objective on shares of Intuitive Surgical in a report on Friday, January 26th. Zacks Investment Research lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Friday, January 26th. ValuEngine lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Piper Jaffray Companies reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Friday, January 26th. Finally, Vetr raised Intuitive Surgical from a “buy” rating to a “strong-buy” rating and set a $478.64 target price on the stock in a report on Monday, March 19th. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. Intuitive Surgical presently has a consensus rating of “Buy” and a consensus target price of $457.59.

  • [By ]

    As of the time of this article, home cleaning robot maker iRobot’s (IRBT) shares are down over 6% on the news. And though it makes surgical robots rather than anything meant for homes, Intuitive Surgical  (ISRG) is down close to 2%. As usual, Wall Street immediately trembles on any sign that Amazon plans to further expand its reach.

  • [By Ethan Ryder]

    Intuitive Surgical, Inc. (NASDAQ:ISRG)’s share price hit a new 52-week high during trading on Friday . The stock traded as high as $498.06 and last traded at $496.25, with a volume of 13472 shares trading hands. The stock had previously closed at $488.97.

  • [By ]

    And stocks are following suit. Intuitive Surgical (NASDAQ: ISRG) for example, has been on strong, steady climb for the better part of a year.

  • [By Motley Fool Staff]

    Stock No. 4: Let’s go to the “I” stock from our April stocks a year ago. That’s one of my favorite companies, a stock that I own, and have held for more than a decade, and that would be Intuitive Surgical (NASDAQ:ISRG), the maker of the da Vinci robot, the surgical robot.

Top 10 Growth Stocks To Buy Right Now: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Joseph Griffin]

    MediBloc (CURRENCY:MED) traded 6.8% lower against the dollar during the 1-day period ending at 15:00 PM Eastern on May 27th. MediBloc has a total market cap of $73.40 million and $743,880.00 worth of MediBloc was traded on exchanges in the last 24 hours. One MediBloc token can currently be purchased for approximately $0.0247 or 0.00000339 BTC on major cryptocurrency exchanges including Bibox, Gate.io and Coinrail. During the last seven days, MediBloc has traded 8.3% higher against the dollar.

  • [By Joseph Griffin]

    MediBloc [QRC] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. Its genesis date was January 3rd, 2014. MediBloc [QRC]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. The official website for MediBloc [QRC] is medibloc.org/en. MediBloc [QRC]’s official Twitter account is @MEDDevTeam. The Reddit community for MediBloc [QRC] is /r/MediBloc and the currency’s Github account can be viewed here. The official message board for MediBloc [QRC] is medium.com/@MediBloc.

  • [By Max Byerly]

    MediBloc (CURRENCY:MED) traded 0.2% lower against the U.S. dollar during the twenty-four hour period ending at 16:00 PM Eastern on June 7th. MediBloc has a total market cap of $37.92 million and $586,074.00 worth of MediBloc was traded on exchanges in the last 24 hours. Over the last week, MediBloc has traded down 36% against the U.S. dollar. One MediBloc token can now be purchased for $0.0128 or 0.00000166 BTC on major exchanges including Coinrail, Bibox and Gate.io.

Top 10 Growth Stocks To Buy Right Now: Nordstrom Inc.(JWN)

Advisors’ Opinion:

  • [By JJ Kinahan]

    This week brings a string of retail results with reports from Walmart Inc. (NYSE: WMT) on Thursday morning and Nordstrom, Inc. (NYSE: JWN) after market close the same day. Next week, big-box retailer Target Corporation (NYSE: TGT) and home improvement retailer Lowe’s Companie, Inc. (NYSE: LOW) both report before market open on Wednesday, May 23. For a look at what else is going on across markets, check out today’s market update if you have time.

  • [By ]

    On Thursday, earnings are expected from JCPenney Co. (JCP) , Action Alerts PLUS holding Nordstrom Inc. (JWN) , Nintendo Co. (NTDOY) and Walmart Inc. (WMT) .

  • [By Paul Ausick]

    Nordstrom Inc. (NYSE: JWN) reported fourth-quarter and full fiscal-year 2017 results after markets closed Thursday evening. The department store giant posted quarterly diluted earnings per share (EPS) of $0.89 on revenues of $4.7 billion. In the same period a year ago, Nordstrom reported EPS of $1.27 on revenues of $4.32 billion. Fourth-quarter results compare to the consensus estimates for EPS of $1.24 and $4.62 billion in revenue. EPS includes a negative impact of $0.31 per share related to changes in U.S. tax law.

  • [By Dan Caplinger]

    Wall Street was in a great mood on Thursday, as favorable news on multiple fronts sent the Dow Jones Industrial Average to its first record close in eight months. Major benchmarks were generally up 1% after market participants responded to strong economic data on jobless claims, and rising optimism about the potential for a peaceful solution to the tariff-laden trade environment helped many Dow components disproportionately. However, some companies still had to deal with individual challenges that kept them from joining the rally. Stitch Fix (NASDAQ:SFIX), Nordstrom (NYSE:JWN), and Tilray (NASDAQ:TLRY) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Steve Symington]

    But several individual companies bucked the indexes’ trend. Read on to learn why MiMedx Group (NASDAQ:MDXG), Core Laboratories (NYSE:CLB), and Nordstrom (NYSE:JWN) trailed the broader market today.

Top 5 Growth Stocks To Own For 2019

This analysis will show why we think OpenText (OTEX) is one of the few undervalued companies in the technology sector. Per the fiscal 2017 annual report, OpenText made progress expanding into the enterprise information management such that the company sees a total addressable market size of $35 billion. Given the overall market size and associated need of enterprise information management, OpenText expects to have long-term strategic flexibility with attractive options to grow the business. OpenText’s software assists organizations with efficiently finding, utilizing, and sharing business information to improve productivity. The company also provides solutions that facilitate the exchange of information and transactions between supply chain participants such as manufacturers, retailers, distributors, and financial institutions. By unlocking massive amounts of data, OpenText helps its customers gain better insight into their business to improve decision making. The company offers solutions for almost every industry and its software offerings integrate with most of the main business software providers such as SAP (SAP), Microsoft (MSFT), Oracle (ORCL), and SalesForce (CRM). The company plans to mainly fuel growth through M&A. The company has already closed 57 acquisitions including ANX, HP CEM, Recommind, HP CCM, and the enterprise content division of Dell-EMC in fiscal 2017. In fiscal 2018, the company acquired Covisant and announced the intention of acquiring Guidance software, an information forensics company that will strengthen OpenText’s eDiscovery offerings. Electronic discovery or eDiscovery refers to finding and securing electronic data in order to search it for use as evidence in legal cases. One thing to note about the Guidance acquisition is that in addition to diversifying OpenText’s offerings via eDiscovery tools, Guidance Software also comes with a customer list that includes 78 of the Fortune 100 companies, per the Guidance website.

Top 5 Growth Stocks To Own For 2019: Nordstrom Inc.(JWN)

Advisors’ Opinion:

  • [By Chris Lange]

    Nordstrom Inc. (NYSE: JWN) shares pulled back on Tuesday after the department store chain announced its sales projections for the next five years. Ultimately its targets were not up to par with what Wall Street had in mind.

  • [By Taylor Cox]

    Notable Earnings

    Walmart, Inc (NYSE: WMT) Q1 premarket
    J. C. Penney (NYSE: JCP) Q1 premarket
    Nordstrom, Inc (NYSE: JWN) Q1 after hours
    Applied Materials, Inc (NASDAQ: AMAT) Q2 after hours

    IPOs

  • [By Adam Levine-Weinberg]

    Over the past decade, Nordstrom (NYSE:JWN) has been one of the most forward-thinking department stores in terms of rolling out new technology and testing innovative ways to serve customers. However, you wouldn’t know it from the company’s financial results.

Top 5 Growth Stocks To Own For 2019: Intuitive Surgical Inc.(ISRG)

Advisors’ Opinion:

  • [By Brian Stoffel]

    Investors in Intuitive Surgical (NASDAQ:ISRG) know the script by now. The company forecasts solid — but not heady — procedure growth. When the end of the quarter comes, not only does it exceed expectations, but it also sells significantly more daVinci systems than it did the year before.

  • [By Keith Speights]

    At first glance, Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ) might seem to have little in common other than they both sell medical instruments. However, Johnson & Johnson could eventually compete against Intuitive Surgical in the surgical robotics market thanks to its Verb Surgical joint venture with Alphabet’s Verily Life Sciences. 

  • [By Brian Feroldi]

    Medtronic (NYSE:MDT) and Intuitive Surgical (NASDAQ:ISRG) are two of the most successful medical device companies of all time.

    Medtronic has been hawking medical devices since it was founded in 1949, and it has been a stellar long-term investment. The company has turned into such a steady-eddy business that it has raised its dividend for 41 years in a row.

  • [By Keith Speights]

    Intuitive Surgical (NASDAQ:ISRG) is best known for its da Vinci robotic surgical system. Johnson & Johnson (NYSE:JNJ) might be most famous for its consumer healthcare products. But there’s a lot more to picking between these two stocks than just comparing robots and Band-Aids.

  • [By Anders Bylund]

    Shares of Intuitive Surgical (NASDAQ:ISRG) rose 31.1% in the first half of 2018, according to data from S&P Global Market Intelligence. The maker of the da Vinci line of robotic surgery tools crushed Wall Street’s expectations in both of the earnings reports that were presented in this six-month span.

  • [By Logan Wallace]

    Sanford C. Bernstein began coverage on shares of Intuitive Surgical (NASDAQ:ISRG). Sanford C. Bernstein issued an outperform rating on the stock.

    Argus started coverage on shares of Integer (NYSE:ITGR). The firm issued a buy rating on the stock.

Top 5 Growth Stocks To Own For 2019: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

  • [By Logan Wallace]

    Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.

  • [By Logan Wallace]

    ValuEngine downgraded shares of Trueblue (NYSE:TBI) from a hold rating to a sell rating in a report issued on Friday morning.

    Several other research firms have also recently weighed in on TBI. Zacks Investment Research cut shares of Trueblue from a hold rating to a sell rating in a research report on Tuesday, February 12th. BMO Capital Markets decreased their price objective on shares of Trueblue from $26.00 to $24.00 and set a market perform rating for the company in a research report on Monday, February 11th. TheStreet cut shares of Trueblue from a b- rating to a c rating in a research report on Monday, December 31st. Finally, Credit Suisse Group decreased their price objective on shares of Trueblue from $31.00 to $25.00 and set a hold rating for the company in a research report on Tuesday, November 6th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. Trueblue presently has an average rating of Hold and a consensus price target of $26.00.

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.

Top 5 Growth Stocks To Own For 2019: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Logan Wallace]

    State Board of Administration of Florida Retirement System raised its stake in Medifast Inc (NYSE:MED) by 12.4% during the second quarter, HoldingsChannel reports. The institutional investor owned 5,781 shares of the specialty retailer’s stock after buying an additional 640 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Medifast were worth $926,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. MediBloc [QRC20]’s official website is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The official message board for MediBloc [QRC20] is medium.com/@MediBloc. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 20 percent to $119 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Ethan Ryder]

    MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 25 percent to $124.60 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Sean Williams]

    Meanwhile, Medifast’s (NYSE:MED) share price has tripled since the beginning of March. Medifast’s second-quarter operating results showcased a 55% increase in sales and an 84% improvement in year-over-year adjusted earnings per share. A substantial increase in Optavia-branded products sold, along with a big jump in active earning coaches, drove results. The company also substantially lifted its full-year sales and profit guidance (close to 20% at the midpoint for both measures). 

Top 5 Growth Stocks To Own For 2019: Buffalo Wild Wings Inc.(BWLD)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen’s clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby’s Restaurant Group:

  • [By Steve Symington]

    That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

Top 10 Growth Stocks To Buy For 2019

&l;a href=&q;http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=mu&a;amp;tab=searchtabquotesdark&q; target=&q;_blank&q;&g;Micron&l;/a&g; (NYSE: MU) has seen impressive growth in recent years. The company&a;rsquo;s revenue grew 64% and its stock price doubled in 2017. The company expects the favorable demand-supply environment to persist in the year ahead, supported by continued strong growth in both DRAM and NAND demand, reflecting broader trends in the data center and mobile markets as well as increased adoption of SSDs across enterprise, cloud, and client PCs.

Currently, we have a price estimate for &l;a href=&q;http://www.trefis.com/company?hm=MU.trefis&a;amp;from=search#&q; target=&q;_blank&q;&g;Micron Technology of $60&l;/a&g;, which is ahead of the market price. We have also created an &l;a href=&q;http://dashboards.trefis.com/no-login-required/8LJsz38S?fromforbesandarticle=a-closer-look-at-our-60-price-estimate-for-micron-technology&q; target=&q;_blank&q;&g;&l;strong&g;interactive dashboard &l;/strong&g;&l;/a&g;which shows our forecasts and estimates for the company; you can modify the key value drivers to see how they impact the company&a;rsquo;s revenues, bottom line, and valuation.

Top 10 Growth Stocks To Buy For 2019: Nordstrom Inc.(JWN)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Nordstrom, Inc. (NYSE:JWN)Q1 2018 Earnings Conference CallMay 17, 2017, 4:45 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Leo Sun]

    Nordstrom’s (NYSE:JWN) shares tumbled 11% to a year-to-date low on May 18 after the high-end retailer reported its first quarter earnings. That drop was surprising, since the company beat expectations on the top and bottom lines.

  • [By Dan Caplinger]

    Wall Street was in a great mood on Thursday, as favorable news on multiple fronts sent the Dow Jones Industrial Average to its first record close in eight months. Major benchmarks were generally up 1% after market participants responded to strong economic data on jobless claims, and rising optimism about the potential for a peaceful solution to the tariff-laden trade environment helped many Dow components disproportionately. However, some companies still had to deal with individual challenges that kept them from joining the rally. Stitch Fix (NASDAQ:SFIX), Nordstrom (NYSE:JWN), and Tilray (NASDAQ:TLRY) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Chris Lange]

    Nordstrom Inc. (NYSE: JWN) is scheduled to release its most recent quarterly results after the markets close on Thursday. The consensus estimates call for $0.44 in earnings per share (EPS) on $3.46 billion in revenue. The fiscal first quarter of last year reportedly had EPS of $0.37 and $3.35 billion in revenue.

  • [By Zacks]

    We have Macy's (NYSE: M), Nordstrom (NYSE: JWN), Wal-Mart (NYSE: WMT), and Home Depot (NYSE: HD) reporting this week.  While the earnings reports will give us the historical data, this week's retail sales data will give us some insight on how well the sector is doing overall in the beginning of Q2.

Top 10 Growth Stocks To Buy For 2019: Intuitive Surgical Inc.(ISRG)

Advisors’ Opinion:

  • [By Brian Stoffel]

    While I have faith in all the stocks in my portfolio, five stick out as high-conviction picks for the next five years. All five have demonstrated they can defend their core business, while pursuing profitable ways to further their missions. These five are Amazon (NASDAQ:AMZN), Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL), Intuitive Surgical (NASDAQ:ISRG), Axon Enterprise (NASDAQ:AAXN), and Tencent Holdings (NASDAQOTH:TCEHY)

  • [By Stephan Byrd]

    Intuitive Surgical (NASDAQ:ISRG) announced its quarterly earnings results on Wednesday. The medical equipment provider reported $2.76 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.28, Bloomberg Earnings reports. The company had revenue of $909.30 million during the quarter, compared to analysts’ expectations of $877.43 million. Intuitive Surgical had a return on equity of 20.72% and a net margin of 23.25%. Intuitive Surgical’s quarterly revenue was up 19.8% on a year-over-year basis. During the same period last year, the business earned $5.95 earnings per share.

  • [By Todd Campbell, Chris Neiger, and Sean Williams]

    There are thousands of stocks investors can buy, so deciding which make the most sense to own in long-term portfolios, such as retirement accounts, can be tough. Economies can rise and fall, and competitors can disrupt business models, but our three Motley Fool contributors think Illumina (NASDAQ:ILMN), Intuitive Surgical (NASDAQ:ISRG), and Amazon (NASDAQ:AMZN) have what it takes to reward investors over the long haul. Read on to see what separates these stocks from the countless others that you could stash away for 20 years or more.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Intuitive Surgical, Inc. (NASDAQ: ISRG) which rose over 6% to $423.76. The stock’s 52-week range is $217.19 to $426.98. Volume was 1.7 million compared to its average volume of nearly 1 million.

Top 10 Growth Stocks To Buy For 2019: Buffalo Wild Wings Inc.(BWLD)

Advisors’ Opinion:

  • [By Steve Symington]

    That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen’s clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby’s Restaurant Group:

Top 10 Growth Stocks To Buy For 2019: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Ethan Ryder]

    MediBloc (CURRENCY:MED) traded 3.9% lower against the U.S. dollar during the 1-day period ending at 20:00 PM E.T. on June 13th. One MediBloc token can now be purchased for $0.0083 or 0.00000131 BTC on major cryptocurrency exchanges including Coinrail, Gate.io and Bibox. During the last seven days, MediBloc has traded 36.5% lower against the U.S. dollar. MediBloc has a total market cap of $24.58 million and $216,935.00 worth of MediBloc was traded on exchanges in the last day.

  • [By Joseph Griffin]

    MediBloc (CURRENCY:MED) traded 6.8% lower against the dollar during the 1-day period ending at 15:00 PM Eastern on May 27th. MediBloc has a total market cap of $73.40 million and $743,880.00 worth of MediBloc was traded on exchanges in the last 24 hours. One MediBloc token can currently be purchased for approximately $0.0247 or 0.00000339 BTC on major cryptocurrency exchanges including Bibox, Gate.io and Coinrail. During the last seven days, MediBloc has traded 8.3% higher against the dollar.

  • [By Ethan Ryder]

    MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.

  • [By Sean Williams]

    Meanwhile, Medifast’s (NYSE:MED) share price has tripled since the beginning of March. Medifast’s second-quarter operating results showcased a 55% increase in sales and an 84% improvement in year-over-year adjusted earnings per share. A substantial increase in Optavia-branded products sold, along with a big jump in active earning coaches, drove results. The company also substantially lifted its full-year sales and profit guidance (close to 20% at the midpoint for both measures). 

Top 10 Growth Stocks To Buy For 2019: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Trueblue (TBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.

  • [By Motley Fool Transcribers]

    TrueBlue Inc  (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Media stories about Trueblue (NYSE:TBI) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.3296498009881 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Joseph Griffin]

    Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.